AMERIPRISE FINANCIAL INC

Position in KURA — Kura Oncology, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in KURA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,244,615

+$405,935 QoQ

Shares Held

204,614

-9.5% QoQ

Ownership

0.230%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#53

of 220 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 0% Shared 99% None 1%

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. KURA ranks #126 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,604,822	$1,293,893,227
2	INSM	INSMED Inc	6,179,571	$658,865,856
3	JAZZ	Jazz Pharmaceuticals plc	1,215,523	$292,904,576
4	RVMD	Revolution Medicines, Inc.	1,039,702	$194,715,388
5	ARGX	Argenx SE	181,464	$168,356,853
6	REGN	Regeneron Pharmaceuticals, Inc.	227,457	$141,828,535
7	MDGL	Madrigal Pharmaceuticals, Inc.	231,205	$124,145,521
8	BBIO	BridgeBio Pharma, Inc.	1,551,663	$115,567,858

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,244,615	204,614	-9.5%	Shares	Defined	2026-08-14
2026-03-31	$1,838,680	226,160	-34.8%	Shares	Defined	2026-05-15
2025-12-31	$3,601,963	346,676	+5.8%	Shares	Defined	2026-02-17
2025-09-30	$2,898,941	327,564	+2428.5%	Shares	Defined	2025-11-14
2025-06-30	$74,750	12,955	+3.8%	Shares	Defined	2025-08-14
2025-03-31	$82,407	12,486	-16.3%	Shares	Defined	2025-05-14
2024-12-31	$130,004	14,926	-91.8%	Shares	Defined	2025-02-14
2024-06-30	$3,758,848	182,557	-92.4%	Shares	Defined	2024-08-14
2021-09-30	$44,783,484	2,391,003	-3.6%	Shares	Defined	2021-11-15
2021-06-30	$51,733,601	2,481,228	+0.3%	Shares	Defined	2021-08-16
2021-03-31	$69,944,078	2,474,145	+133.9%	Shares	Defined	2021-05-17
2020-12-31	$34,543,338	1,057,665	—	Shares	Defined	2021-02-12
No filing history on record for this holder in this stock.